Brendan D. Manning
- Molecular Biology top 0.05%
- Cancer Research top 0.1%
- Physiology top 0.2%
- Oncology top 0.5%
- Epidemiology top 0.5%
- Co-authors
- Lewis C. CantleyAlex TokerGerta HoxhajJingxiang HuangIssam Ben‐SahraChristian C. DibbleAndrew R. TeeJohn Blenis
- Topics
- PI3K/AKT/mTOR signaling in cancer (58 papers)Tuberous Sclerosis Complex Research (27 papers)Metabolism, Diabetes, and Cancer (21 papers)
- Partner nations
- United StatesSpainUnited Kingdom
In The Last Decade
Brendan D. Manning
114 papers receiving 30.5k citations
Hit Papers
Peers
Comparison fields: 5 of 161
- Molecular Biology 22.0k
- Cancer Research 4.9k
- Physiology 4.5k
- Oncology 3.9k
- Epidemiology 3.6k
Countries citing papers authored by Brendan D. Manning
This map shows the geographic impact of Brendan D. Manning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brendan D. Manning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brendan D. Manning more than expected).
Fields of papers citing papers by Brendan D. Manning
This network shows the impact of papers produced by Brendan D. Manning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brendan D. Manning. The network helps show where Brendan D. Manning may publish in the future.
Co-authorship network of co-authors of Brendan D. Manning
This figure shows the co-authorship network connecting the top 25 collaborators of Brendan D. Manning. A scholar is included among the top collaborators of Brendan D. Manning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brendan D. Manning. Brendan D. Manning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 113 | |
| 4 | 55 | |
| 5 | 5 | |
| 6 | mTORC1 signaling and the metabolic control of cell growthbreakdown → | 472 |
| 7 | 224 | |
| 8 | 24 | |
| 9 | Spatial Control of the TSC Complex Integrates Insulin and Nutrient Regulation of mTORC1 at the Lysosomebreakdown → | 613 |
| 10 | 8 | |
| 11 | Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1 | 2 |
| 12 | Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1breakdown → | 1582 |
| 13 | 399 | |
| 14 | 353 | |
| 15 | AKT/PKB Signaling: Navigating Downstreambreakdown → | 4947 |
| 16 | 243 | |
| 17 | Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signalingbreakdown → | 647 |
| 18 | 85 | |
| 19 | Identification of the Tuberous Sclerosis Complex-2 Tumor Suppressor Gene Product Tuberin as a Target of the Phosphoinositide 3-Kinase/Akt Pathwaybreakdown → | 1281 |
| 20 | 151 |
About Brendan D. Manning
Brendan D. Manning is a scholar working on Aging, Cancer Research and Molecular Biology, having authored 118 papers that have together received 30.9k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (58 papers), Tuberous Sclerosis Complex Research (27 papers) and Metabolism, Diabetes, and Cancer (21 papers). The work is most often cited by research in Aging (604 citations), Cancer Research (4.9k citations) and Molecular Biology (22.0k citations). Brendan D. Manning has collaborated with scholars based in United States, Spain and United Kingdom. Frequent co-authors include Lewis C. Cantley, Alex Toker, Gerta Hoxhaj, Jingxiang Huang, Issam Ben‐Sahra, Christian C. Dibble, Andrew R. Tee, John Blenis, John M. Asara and David J. Kwiatkowski. Their work appears in journals such as Nature, Science and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.